Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
11 05 2020
Historique:
received: 08 05 2020
accepted: 10 05 2020
pubmed: 12 5 2020
medline: 1 7 2020
entrez: 12 5 2020
Statut: epublish

Résumé

Significant differences exist in the availability of healthcare worker (HCW) SARS-CoV-2 testing between countries, and existing programmes focus on screening symptomatic rather than asymptomatic staff. Over a 3 week period (April 2020), 1032 asymptomatic HCWs were screened for SARS-CoV-2 in a large UK teaching hospital. Symptomatic staff and symptomatic household contacts were additionally tested. Real-time RT-PCR was used to detect viral RNA from a throat+nose self-swab. 3% of HCWs in the Patients admitted to NHS hospitals are now routinely screened for SARS-CoV-2 (the virus that causes COVID-19), and isolated from other patients if necessary. Yet healthcare workers, including frontline patient-facing staff such as doctors, nurses and physiotherapists, are only tested and excluded from work if they develop symptoms of the illness. However, there is emerging evidence that many people infected with SARS-CoV-2 never develop significant symptoms: these people will therefore be missed by ‘symptomatic-only’ testing. There is also important data showing that around half of all transmissions of SARS-CoV-2 happen before the infected individual even develops symptoms. This means that much broader testing programs are required to spot people when they are most infectious. Rivett, Sridhar, Sparkes, Routledge et al. set out to determine what proportion of healthcare workers was infected with SARS-CoV-2 while also feeling generally healthy at the time of testing. Over 1,000 staff members at a large UK hospital who felt they were well enough to work, and did not fit the government criteria for COVID-19 infection, were tested. Amongst these, 3% were positive for SARS-CoV-2. On closer questioning, around one in five reported no symptoms, two in five very mild symptoms that they had dismissed as inconsequential, and a further two in five reported COVID-19 symptoms that had stopped more than a week previously. In parallel, healthcare workers with symptoms of COVID-19 (and their household contacts) who were self-isolating were also tested, in order to allow those without the virus to quickly return to work and bolster a stretched workforce. Finally, the rates of infection were examined to probe how the virus could have spread through the hospital and among staff – and in particular, to understand whether rates of infection were greater among staff working in areas devoted to COVID-19 patients. Despite wearing appropriate personal protective equipment, healthcare workers in these areas were almost three times more likely to test positive than those working in areas without COVID-19 patients. However, it is not clear whether this genuinely reflects greater rates of patients passing the infection to staff. Staff may give the virus to each other, or even acquire it at home. Overall, this work implies that hospitals need to be vigilant and introduce broad screening programmes across their workforces. It will be vital to establish such approaches before ‘lockdown’ is fully lifted, so healthcare institutions are prepared for any second peak of infections.

Autres résumés

Type: plain-language-summary (eng)
Patients admitted to NHS hospitals are now routinely screened for SARS-CoV-2 (the virus that causes COVID-19), and isolated from other patients if necessary. Yet healthcare workers, including frontline patient-facing staff such as doctors, nurses and physiotherapists, are only tested and excluded from work if they develop symptoms of the illness. However, there is emerging evidence that many people infected with SARS-CoV-2 never develop significant symptoms: these people will therefore be missed by ‘symptomatic-only’ testing. There is also important data showing that around half of all transmissions of SARS-CoV-2 happen before the infected individual even develops symptoms. This means that much broader testing programs are required to spot people when they are most infectious. Rivett, Sridhar, Sparkes, Routledge et al. set out to determine what proportion of healthcare workers was infected with SARS-CoV-2 while also feeling generally healthy at the time of testing. Over 1,000 staff members at a large UK hospital who felt they were well enough to work, and did not fit the government criteria for COVID-19 infection, were tested. Amongst these, 3% were positive for SARS-CoV-2. On closer questioning, around one in five reported no symptoms, two in five very mild symptoms that they had dismissed as inconsequential, and a further two in five reported COVID-19 symptoms that had stopped more than a week previously. In parallel, healthcare workers with symptoms of COVID-19 (and their household contacts) who were self-isolating were also tested, in order to allow those without the virus to quickly return to work and bolster a stretched workforce. Finally, the rates of infection were examined to probe how the virus could have spread through the hospital and among staff – and in particular, to understand whether rates of infection were greater among staff working in areas devoted to COVID-19 patients. Despite wearing appropriate personal protective equipment, healthcare workers in these areas were almost three times more likely to test positive than those working in areas without COVID-19 patients. However, it is not clear whether this genuinely reflects greater rates of patients passing the infection to staff. Staff may give the virus to each other, or even acquire it at home. Overall, this work implies that hospitals need to be vigilant and introduce broad screening programmes across their workforces. It will be vital to establish such approaches before ‘lockdown’ is fully lifted, so healthcare institutions are prepared for any second peak of infections.

Identifiants

pubmed: 32392129
doi: 10.7554/eLife.58728
pii: 58728
pmc: PMC7314537
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : Wellcome
ID : 206298/B/17/Z
Pays : International
Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom
Organisme : National Institute for Health Research
ID : Cambridge Biomedical Research Centre
Pays : International
Organisme : Engineering and Physical Sciences Research Council
ID : EP/N031938/1
Pays : International
Organisme : Wellcome
ID : 210688/Z/18/Z
Pays : International
Organisme : Wellcome
ID : 108070/Z/15/Z
Pays : International
Organisme : Academy of Medical Sciences
ID : Clinician Scientist Fellowship
Pays : United Kingdom
Organisme : Cancer Research UK
ID : PRECISION Grand Challenge C38317/A24043
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V011561/1
Pays : United Kingdom
Organisme : Wellcome
ID : 200871/Z/16/Z
Pays : International
Organisme : Medical Research Council
ID : MR/P008801/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome
ID : 215515/Z/19/Z
Pays : International
Organisme : NHS Blood and Transplant
ID : WPA15-02
Pays : International
Organisme : Engineering and Physical Sciences Research Council
ID : EP/P031447/1
Pays : International
Organisme : Wellcome
ID : 207498?Z/17/Z
Pays : International

Investigateurs

Ravi Gupta (R)
Paul A Lyons (PA)
Mark Toshner (M)
Ben Warne (B)
Josefin Bartholdson Scott (J)
Claire Cormie (C)
Harmeet Gill (H)
Iain Kean (I)
Mailis Maes (M)
Nicola Reynolds (N)
Michelle Wantoch (M)
Sarah Caddy (S)
Laura Caller (L)
Theresa Feltwell (T)
Grant Hall (G)
Myra Hosmillo (M)
Charlotte Houldcroft (C)
Aminu Jahun (A)
Fahad Khokhar (F)
Anna Yakovleva (A)
Helen Butcher (H)
Daniela Caputo (D)
Debra Clapham-Riley (D)
Helen Dolling (H)
Anita Furlong (A)
Barbara Graves (B)
Emma Le Gresley (EL)
Nathalie Kingston (N)
Sofia Papadia (S)
Hannah Stark (H)
Kathleen E Stirrups (KE)
Jennifer Webster (J)
Joanna Calder (J)
Julie Harris (J)
Sarah Hewitt (S)
Jane Kennet (J)
Anne Meadows (A)
Rebecca Rastall (R)
Criona O Brien (CO)
Jo Price (J)
Cherry Publico (C)
Jane Rowlands (J)
Valentina Ruffolo (V)
Hugo Tordesillas (H)
Karen Brookes (K)
Laura Canna (L)
Isabel Cruz (I)
Katie Dempsey (K)
Anne Elmer (A)
Naidine Escoffery (N)
Heather Jones (H)
Carla Ribeiro (C)
Caroline Saunders (C)
Angela Wright (A)
Rutendo Nyagumbo (R)
Anne Roberts (A)
Ashlea Bucke (A)
Simone Hargreaves (S)
Danielle Johnson (D)
Aileen Narcorda (A)
Debbie Read (D)
Christian Sparke (C)
Lucy Warboys (L)
Kirsty Lagadu (K)
Lenette Mactavous (L)
Tim Gould (T)
Tim Raine (T)
Claire Mather (C)
Nicola Ramenatte (N)
Anne-Laure Vallier (AL)
Mary Kasanicki (M)
Penelope-Jane Eames (PJ)
Chris McNicholas (C)
Lisa Thake (L)
Neil Bartholomew (N)
Nick Brown (N)
Surendra Parmar (S)
Hongyi Zhang (H)
Ailsa Bowring (A)
Geraldine Martell (G)
Natalie Quinnell (N)
Jo Wright (J)
Helen Murphy (H)
Benjamin J Dunmore (BJ)
Ekaterina Legchenko (E)
Stefan Gräf (S)
Christopher Huang (C)
Josh Hodgson (J)
Kelvin Hunter (K)
Jennifer Martin (J)
Federica Mescia (F)
Ciara O'Donnell (C)
Linda Pointon (L)
Joy Shih (J)
Rachel Sutcliffe (R)
Tobias Tilly (T)
Zhen Tong (Z)
Carmen Treacy (C)
Jennifer Wood (J)
Laura Bergamaschi (L)
Ariana Betancourt (A)
Georgie Bowyer (G)
Aloka De Sa (A)
Maddie Epping (M)
Andrew Hinch (A)
Oisin Huhn (O)
Isobel Jarvis (I)
Daniel Lewis (D)
Joe Marsden (J)
Simon McCallum (S)
Francescsa Nice (F)

Informations de copyright

© 2020, Rivett et al.

Déclaration de conflit d'intérêts

LR, SS, DS, MR, NJ, SF, JY, JP, WH, MF, LM, MC, SF, AS, JB, GW No competing interests declared, MT Reports grants from Academy of Medical Sciences and the Health Foundation, non-financial support from National Institute of Health Research, grants from Medical Research Council, grants from Global Challenges Research Fund, personal fees from Wellcome Sanger Institute, personal fees from University of Cambridge, personal fees from Oxford University Press, AC Reports grants from Cambridge Biomedical Research Centre at CUHNFT, RS Reports grants from EPSRC fellowship, GD Reports grants from NIHR, KS, MW Reports grants from Wellcome Trust, PL, IG, SB Reports grants from Wellcome Trust and Addenbrooke's Charitable Trust, NM Reports grants from MRC (UK) and NHS Blood and Transfusion

Auteurs

Lucy Rivett (L)

Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
Clinical Microbiology and Public Health Laboratory, Public Health England, Cambridge, United Kingdom.

Sushmita Sridhar (S)

Wellcome Sanger Institute, Hinxton, United Kingdom.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.

Dominic Sparkes (D)

Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
Clinical Microbiology and Public Health Laboratory, Public Health England, Cambridge, United Kingdom.

Matthew Routledge (M)

Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
Clinical Microbiology and Public Health Laboratory, Public Health England, Cambridge, United Kingdom.

Nick K Jones (NK)

Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
Clinical Microbiology and Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.

Sally Forrest (S)

Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.

Jamie Young (J)

Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.

Joana Pereira-Dias (J)

Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.

William L Hamilton (WL)

Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
Clinical Microbiology and Public Health Laboratory, Public Health England, Cambridge, United Kingdom.

Mark Ferris (M)

Occupational Health and Wellbeing, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

M Estee Torok (ME)

Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
Department of Microbiology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.

Luke Meredith (L)

Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.

Martin D Curran (MD)

Clinical Microbiology and Public Health Laboratory, Public Health England, Cambridge, United Kingdom.

Stewart Fuller (S)

National Institutes for Health Research Cambridge, Clinical Research Facility, Cambridge, United Kingdom.

Afzal Chaudhry (A)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

Ashley Shaw (A)

National Institutes for Health Research Cambridge, Clinical Research Facility, Cambridge, United Kingdom.

Richard J Samworth (RJ)

Statistical Laboratory, Centre for Mathematical Sciences, Cambridge, United Kingdom.

John R Bradley (JR)

Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
National Institutes for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom.

Gordon Dougan (G)

Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.

Kenneth Gc Smith (KG)

Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.

Paul J Lehner (PJ)

Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.

Nicholas J Matheson (NJ)

Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
NHS Blood and Transplant, Cambridge, United Kingdom.

Giles Wright (G)

Occupational Health and Wellbeing, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

Ian G Goodfellow (IG)

Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.

Stephen Baker (S)

Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.

Michael P Weekes (MP)

Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH